230 related articles for article (PubMed ID: 36207533)
1. MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes.
Sullivan DK; Deutzmann A; Yarbrough J; Krishnan MS; Gouw AM; Bellovin DI; Adam SJ; Liefwalker DF; Dhanasekaran R; Felsher DW
Oncogene; 2022 Nov; 41(45):4960-4970. PubMed ID: 36207533
[TBL] [Abstract][Full Text] [Related]
2. MYC, metabolism, cell growth, and tumorigenesis.
Dang CV
Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906881
[TBL] [Abstract][Full Text] [Related]
3. Measuring MYC-Mediated Metabolism in Tumorigenesis.
Tang HY; Goldman AR; Zhang X; Speicher DW; Dang CV
Methods Mol Biol; 2021; 2318():231-239. PubMed ID: 34019293
[TBL] [Abstract][Full Text] [Related]
4. MYC and the control of DNA replication.
Dominguez-Sola D; Gautier J
Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890833
[TBL] [Abstract][Full Text] [Related]
5. MYC, Metabolic Synthetic Lethality, and Cancer.
Hsieh AL; Dang CV
Recent Results Cancer Res; 2016; 207():73-91. PubMed ID: 27557535
[TBL] [Abstract][Full Text] [Related]
6. Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation.
Ji H; Wu G; Zhan X; Nolan A; Koh C; De Marzo A; Doan HM; Fan J; Cheadle C; Fallahi M; Cleveland JL; Dang CV; Zeller KI
PLoS One; 2011; 6(10):e26057. PubMed ID: 22039435
[TBL] [Abstract][Full Text] [Related]
7. Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma.
Deutzmann A; Sullivan DK; Dhanasekaran R; Li W; Chen X; Tong L; Mahauad-Fernandez WD; Bell J; Mosley A; Koehler AN; Li Y; Felsher DW
Nat Commun; 2024 Feb; 15(1):963. PubMed ID: 38302473
[TBL] [Abstract][Full Text] [Related]
8. MYC activation is a hallmark of cancer initiation and maintenance.
Gabay M; Li Y; Felsher DW
Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890832
[TBL] [Abstract][Full Text] [Related]
9. MYC on the path to cancer.
Dang CV
Cell; 2012 Mar; 149(1):22-35. PubMed ID: 22464321
[TBL] [Abstract][Full Text] [Related]
10. MYC, Metabolism, and Cancer.
Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
[TBL] [Abstract][Full Text] [Related]
11. Of mice and Myc: c-Myc and mammary tumorigenesis.
Jamerson MH; Johnson MD; Dickson RB
J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):27-37. PubMed ID: 15082916
[TBL] [Abstract][Full Text] [Related]
12. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.
Poli V; Fagnocchi L; Fasciani A; Cherubini A; Mazzoleni S; Ferrillo S; Miluzio A; Gaudioso G; Vaira V; Turdo A; Gaggianesi M; Chinnici A; Lipari E; Bicciato S; Bosari S; Todaro M; Zippo A
Nat Commun; 2018 Mar; 9(1):1024. PubMed ID: 29523784
[TBL] [Abstract][Full Text] [Related]
13. The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo.
Osthus RC; Karim B; Prescott JE; Smith BD; McDevitt M; Huso DL; Dang CV
Cancer Res; 2005 Jul; 65(13):5620-7. PubMed ID: 15994934
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
Aravalli RN; Talbot NC; Steer CJ
World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
[TBL] [Abstract][Full Text] [Related]
15. c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.
Ciribilli Y; Singh P; Inga A; Borlak J
Oncotarget; 2016 Oct; 7(40):65514-65539. PubMed ID: 27602772
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis.
Wu CH; Sahoo D; Arvanitis C; Bradon N; Dill DL; Felsher DW
PLoS Genet; 2008 Jun; 4(6):e1000090. PubMed ID: 18535662
[TBL] [Abstract][Full Text] [Related]
17. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.
Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J
Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040
[TBL] [Abstract][Full Text] [Related]
18. Examining Myc-Dependent Translation Changes in Cellular Homeostasis and Cancer.
Kovalski JR; Xu Y; Ruggero D
Methods Mol Biol; 2021; 2318():255-266. PubMed ID: 34019295
[TBL] [Abstract][Full Text] [Related]
19. STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma.
Bisikirska BC; Adam SJ; Alvarez MJ; Rajbhandari P; Cox R; Lefebvre C; Wang K; Rieckhof GE; Felsher DW; Califano A
Oncogene; 2013 Nov; 32(45):5283-91. PubMed ID: 23178486
[TBL] [Abstract][Full Text] [Related]
20. MYC's Fine Line Between B Cell Development and Malignancy.
de Barrios O; Meler A; Parra M
Cells; 2020 Feb; 9(2):. PubMed ID: 32102485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
